Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05242965
What this trial is testing

A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
University of Washington 40
Testing effectiveness (Phase 2)UnknownNCT05975944
What this trial is testing

Study of Selinexor Combined With Olaparib in Relapsed/Refractory Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 49
Testing effectiveness (Phase 2)Looking for participantsNCT07288177
What this trial is testing

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Genmab 240
Large-scale testing (Phase 3)Active Not RecruitingNCT06732401
What this trial is testing

Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 630
Not applicableStudy completedNCT01414595
What this trial is testing

Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 248
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Testing effectiveness (Phase 2)UnknownNCT03841136
What this trial is testing

Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Fudan University 70
Testing effectiveness (Phase 2)Looking for participantsNCT06440954
What this trial is testing

Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases

Who this might be right for
Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital 220
Early research (Phase 1)Study completedNCT03023319
What this trial is testing

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungMesotheliomaBladder Cancer+5 more
Nagla Abdel Karim 6
Early research (Phase 1)Ended earlyNCT04622072
What this trial is testing

XZP-5809-TT1 Tablets in Patients With T790M Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Sihuan Pharmaceutical Holdings Group Ltd. 21
Testing effectiveness (Phase 2)Looking for participantsNCT07489066
What this trial is testing

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Who this might be right for
CarcinomaNon-Small-Cell LungLung Cancer (NSCLC)+6 more
Pfizer 120
Early research (Phase 1)Ended earlyNCT06599502
What this trial is testing

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
AstraZeneca 17
Testing effectiveness (Phase 2)Study completedNCT04120454
What this trial is testing

Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8+2 more
Ohio State University Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT00003495
What this trial is testing

Antineoplaston Therapy in Treating Patients With Recurrent or Stage IV Lung Cancer

Who this might be right for
Stage IV Lung Cancer
Burzynski Research Institute 7
Testing effectiveness (Phase 2)Study completedNCT00960999
What this trial is testing

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 94
Testing effectiveness (Phase 2)Active Not RecruitingNCT02696993
What this trial is testing

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 80
Early research (Phase 1)Study completedNCT06307093
What this trial is testing

Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

Who this might be right for
Skin MelanomaSquamous Non-small-cell Lung CancerHead and Neck Squamous Cell Carcinoma
R-Pharm 90
Testing effectiveness (Phase 2)Study completedNCT00445198
What this trial is testing

A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Who this might be right for
Small Cell Lung CancerSmall Cell Lung Carcinoma
AbbVie (prior sponsor, Abbott) 86
Testing effectiveness (Phase 2)Study completedNCT06249854
What this trial is testing

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Korea Institute of Oriental Medicine 26
Testing effectiveness (Phase 2)Looking for participantsNCT06199895
What this trial is testing

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Who this might be right for
Pancreatic AdenocarcinomaCholangiocarcinomaLung Cancer+3 more
Liu Huang 25
Next Page